Effect of a new marker, ADAM12, on Down risk figures in first trimester screening

By Valinen Yrtti   Laitinen Paivi   Ranta Jenni   Ignatius Jaakko   Jarvela Ilkka   Ryynanen Markku  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 22, Iss. 7, 2009-07 ,pp. : 602-607

Informa Healthcare

Access to resources Recommend Favorite

Adding ADAM12 in risk calculation program does not improve the detection rate of trisomies 18 and 13 in first trimester screening

By Valinen Yrtti   Marttala Jaana   Sahravand Maarit   Jarvela Ilkka   Honkasalo Timppa   Laitinen Paivi   Ryynanen Markku  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 25, Iss. 6, 2012-06 ,pp. : 822-825

Informa Healthcare

Access to resources Recommend Favorite

The significance of a positive second trimester serum screen for trisomy 18

By Oyelese Yinka   Tobon Luis   Burton Aiyanna   Adamczak Joanna   Ashkinadze Elena   Smulian John C   Canterino Joseph  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 23, Iss. 7, 2010-07 ,pp. : 633-637

Informa Healthcare

Access to resources Recommend Favorite

Trophoblast antigen levels in the first trimester of a trisomy 22 pregnancy

By Wheeler D.M.   Edirisinghe W.R.   Petchell F.   Yovich J.L.   Murch A.R.   Saunders D.M.   Sinosich M.J.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 66, Iss. 2, 1996-06 ,pp. : 197-199

Elsevier

Access to resources Recommend Favorite

Multimodal cancer chemotherapy during the first and second trimester of pregnancy: a case report

By Giannakopoulou C.   Manoura A.   Hatzidaki E.   Korakaki E.   Froudarakis G.   Koumandakis E.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 91, Iss. 1, 2000-07 ,pp. : 95-97

Elsevier

Access to resources Recommend Favorite